Antimicrobial Susceptibility Testing Protocols

Antimicrobial Susceptibility Testing Protocols
by Richard Schwalbe (Editor), Lynn Steele-Moore (Editor), Avery C. Goodwin (Editor)

Product Details
* Hardcover: 432 pages
* Publisher: CRC; 1 edition (May 22, 2007)
* Language: English
* ISBN-10: 0824741005

Book Description
The reported increase in the occurrence of antibiotic-resistant bacteria serves to emphasize the importance of accurate susceptibility testing. This timely guide examines the role of the clinical microbiology lab in integrated patient care. The first section addresses basic susceptibility disciplines such as macro and microbroth dilution, agar dilution, and disk diffusion. The second section considers specialized susceptibility protocols that may be performed by a subset of labs, and emphasizes reproducible results. The third section covers antibiotic development and discusses antibiogram design and use. It includes extensive references and a table of antibiotic classes and common bug-drug susceptibilities.

Download

Viruses vs. Superbugs: A Solution to the Antibioti

Viruses vs. Superbugs: A Solution to the Antibiotics Crisis?
by Thomas Hausler (Author)

Product Details
* Hardcover: 256 pages
* Publisher: Macmillan; 1 edition (May 11, 2006)
* Language: English
* ISBN-10: 1403987645

Book Once upon a time, before penicillin, medicine's perpetual battle with bacterial infection was waged with biological weapons. Phages--viruses that kill bacteria but are harmless to humans--were used to perform duties for which they seemed uniquely destined. The story of bacteriophage therapy, which began in the early twentieth century, is dramatic and frustrating. The drama lies in Swedish science editor Hausler's account of how the ideas of an arrogant rogue scientist, Felix d'Herelle, flew in the faces of his contemporaries and how he persevered to prove his hypotheses, only to see his discovery put on a back burner, at least in the West, when modern antibiotics burst upon the scene. That development would have been fine if it had meant a conclusion to struggle against the likes of strep and staph infections. The problem is, however, that greater and greater numbers of serious bacteria are becoming antibiotic resistant. With nearly 90,000 Americans dying each year because antibiotic treatments are no longer effective, something must be done. Hausler proposes renewed investigation into bacteriophage therapy but paints a dismal picture of its likelihood. It is, he says, effective and organic but unlikely to become a cash cow for pharmaceutical companies.

Download

Mirror